As known multiple sclerosis (MS) is a ... some inflammatory markers in MS patients and their relationships with clinical ..... 320.5 083.0·513.0) 300.0 049.0-937.0).
WARNING This document has been supplied under a CLA Licence. It is protected by copyright and it may not (even for internal purposes) be further copied, stored or on-copied electronically without permission, save as may be permitted by law. The recipient may print out a single copy of any document received electronically.
MINERVA MED 2014;105:229-35
D Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
S. JENSEN, M.D., STEPHEN P. HINSHAW, PH.D., HELENA C. KRAEMER, PH.D., THA LENORA, B.S., JEFFREY H. NEWCORN, M.D., HOWARD B. ABIKOFF, PH.D., N S. MARCH, M.D., L. EUGENE ARNOLD, M.D., DENNIS P. CANTWELL, M.D., H CONNERS, PH.D., GLEN R. ELLIOTT, M.D., LAURENCE L. GREENHILL, M.D., AN, M.D., BETSY HOZA, PH.D., WILLIAM E. PELHAM, PH.D., JOANNE B. SEVERE, M.S., ES M. SWANSON, PH.D., KAREN C. WELLS, PH.D., TIMOTHY WIGAL, PH.D., AND BENEDETTO VITIELLO, M.D.
ABSTRACT
Increased serum levels of some inflammatory markers in patients with multiple sclerosis
evious research has been inconclusive whether attention-deficit/hyperactivity disorder (ADHD), when comor-
tive disorders (oppositional defiant disorder [ODD] or conduct disorder [CD]), with the internalizing disorders depression), or with both, should constitute separate clinical entities. Determination of the clinical significance
DHD + internalizing disorder or ADHD + ODD/CD syndromes could yield better diagnostic decision-making,
5. UY5AL '• f. MER I
